CD40L inhibitor dapirolizumab pegol significantly reduced disease activity and corticosteroid use in patients with SLE in the PHOENYCS GO trial.

ACR 2024 highlighted new guidelines for the screening, treatment, and management of lupus nephritis, stressing prompt kidney biopsy and timely treatment.

Sunshine Lake Pharma Co Ltd. has divulged non-receptor tyrosine-protein kinase TYK2 inhibitors reported to be useful for the treatment of multiple sclerosis, psoriasis, rheumatoid arthritis, atopic ...

Yes, lupus can affect your voice. Lupus can cause inflammation and tissue damage, leading to hoarseness, vocal fatigue, and ...

Lupus and menopause can interact in complex ways, with menopause sometimes worsening lupus symptoms or, in other cases, ...

A considerable percentage of patients with SLE experienced delayed access to specialized care, which was associated with organ damage accrual.

Walk with Us to Cure Lupus will be taking place on Sunday, March 2, 2025 at Lynn University in Boca Raton. The Walk not only ...

Years of translational research have successfully improved treatment outcomes for common dermatological ... Vulvar Lichen Sclerosus, Lupus Erythematosus, Cutaneous, Connective Tissue Diseases, ...

Women with systemic lupus erythematosus face an increased risk for cervical ... inflammatory nature of SLE as well as the use ...

Fate Therapeutics has announced encouraging initial data from the FT819 phase 1 autoimmunity study for people with ...

Despite following the same basic recommendations as the adult guidelines, the pediatric LN guidelines included special ...

A news feature on the research paper "Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition" by Rackear et al. was published in Oncotarget's Volume 15 on November 22, ...